Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

Gerald A. Soff, MD: Examining a New Indication for Romiplostim

December 30, 2021

Dr. Soff discusses results from a phase II study of romiplostim in treating patients with chemotherapy-induced thrombocytopenia. The agent led to high rates of platelet count correction and reduction in transfusion needs.

Advertisement intended for health care professionals

Connect with us:

CURRENT ISSUE
November 2024

Advertisement intended for health care professionals

Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals